The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | D | Dermatologicals | |
| 2 | D06 | Antibiotics and chemotherapeutics for dermatological use | |
| 3 | D06B | Chemotherapeutics for topical use | |
| 4 | D06BX | Other chemotherapeutics | |
| 5 | D06BX01 | Metronidazole |
| Active Ingredient | Description | |
|---|---|---|
| Methronidazole |
Metronidazole is an anti-infectious drug belonging to the pharmacotherapeutic group of nitroimidazole derivatives, which have effect mainly on strict anaerobes. This effect is probably caused by interaction with DNS and different metabolites. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| METROGEL Gel | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| METROSA Gel | European Medicines Agency (EU) | MPI, EU: SmPC | |
| ROSICED Cream | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| ROZEX Cream | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
